Last $76.48 USD
Change Today +0.78 / 1.03%
Volume 572.1K
OCR On Other Exchanges
As of 4:15 PM 01/26/15 All times are local (Market data is delayed by at least 15 minutes).

omnicare inc (OCR) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/23/15 - $76.95
52 Week Low
03/13/14 - $56.41
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for OMNICARE INC (OCR)

omnicare inc (OCR) Related Businessweek News

View More BusinessWeek News

omnicare inc (OCR) Details

Omnicare, Inc. operates as a healthcare services company that specializes in the management of pharmaceutical care in the United States and Canada. It operates through two segments, Long-Term Care Group and Specialty Care Group. The company offers pharmaceuticals, and related pharmacy and ancillary services to long-term care facilities, as well as chronic care facilities and other settings. It also operates institutional pharmacy business serving skilled nursing facilities, assisted living facilities, independent living communities, hospitals, correctional facilities, and other healthcare service providers; and provides pharmacy consulting services, including monthly patient drug therapy evaluations, assistance in compliance with state and federal regulations, as well as offers proprietary clinical and health management programs. In addition, the company provides a suite of technology solutions based on its Omniview Web-based platform as the electronic ordering of prescription refills, proof-of-delivery tracking, and real-time validation of Medicare Part D coverage; intravenous medications and nutrition products, respiratory therapy services, and clinical care planning services; and pharmaceutical case management services for retirees, employees, and dependents. Further, it offers specialty pharmacy and commercialization services for the biopharmaceutical industry; and provides brand support services, supply chain solutions, patient support services, and specialty pharmacy platforms. The company’s specialized drugs deal primarily with specific categories of drugs and disease states, such as rheumatoid arthritis, multiple sclerosis, oncology, and growth hormones. Omnicare, Inc. was founded in 1981 and is headquartered in Cincinnati, Ohio.

13,000 Employees
Last Reported Date: 02/19/14
Founded in 1981

omnicare inc (OCR) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $924.5K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $506.2K
Senior Vice President, General Counsel and Se...
Total Annual Compensation: $485.3K
Compensation as of Fiscal Year 2013.

omnicare inc (OCR) Key Developments

Omnicare Inc. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-12-2015 02:00 PM

Omnicare Inc. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-12-2015 02:00 PM. Venue: Westin St. Francis Hotel, San Francisco, California, United States.

U.S. Files Suit Against Omnicare for Accepting Kickbacks from Abbott Labs

The United States has filed a civil False Claims Act complaint against Omnicare Inc. (OCR) alleging that it solicited and received millions of dollars in kickbacks from pharmaceutical manufacturer Abbott Laboratories (ABT), the Justice Department announced. In its complaint, the United States alleges that Omnicare solicited and received kickbacks from Abbott in exchange for purchasing and recommending the prescription drug Depakote for controlling behavioral disturbances exhibited by dementia patients residing in nursing homes serviced by Omnicare. According to the complaint, Omnicare's pharmacists reviewed nursing home patients' charts at least monthly and made recommendations to physicians on what drugs should be prescribed for those patients. The government alleged that Omnicare touted its influence over physicians in nursing homes in order to secure kickbacks from pharmaceutical companies such as Abbott. The United States alleges that Omnicare disguised the kickbacks it received from Abbott in a variety of ways. Abbott allegedly made payments to Omnicare described as grants and educational funding, even though their true purpose was to induce Omnicare to recommend Depakote. The complaint also alleged that Omnicare entered into agreements with Abbott by which Omnicare was entitled to increasing levels of rebates from Abbott based on the number of nursing home residents serviced and the amount of Depakote prescribed per resident. The complaint alleged that Abbott funded Omnicare management meetings on Amelia Island, Florida, offered tickets to sporting events to Omnicare management, and made other payments to local Omnicare pharmacies.

Omnicare Inc. Adopts Fifth Amended and Restated By-Laws

On December 4, 2014, the board of directors of Omnicare Inc. approved and adopted the fifth amended and restated by-laws of the company, effective as of January 1, 2015. The amended by-laws amend the company's existing fourth amended and restated by-laws to: clarify and expand certain procedures and requirements related to the submission of stockholder proposals, including, among others, requirements that the proposing stockholder notify the company of the number of shares of the company's stock held by the proposing stockholder as of the record date for the meeting, describe any derivative transactions the proposing stockholder has entered into with respect to shares of the company's stock and update the proposal notice; establish certain eligibility requirements for director nominees, including the nominee's agreement to act in accordance with a director's duties under Delaware law, not become party to any agreement that commits the director to vote on an issue in a certain way and not become party to any agreement with respect to compensation, reimbursement or indemnification in connection with the nominee's candidacy or service on the board that has not been disclosed to the company; clarify and expand certain procedures related to calling special meetings of stockholders; designate the Court of Chancery of the State of Delaware as the exclusive forum for certain specified actions, including any derivative action brought on behalf of the company; and make certain other clarifying or conforming changes.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OCR:US $76.48 USD +0.78

OCR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cintas Corp $79.97 USD +0.19
Covance Inc $107.07 USD +0.35
Envision Healthcare Holdings Inc $35.46 USD +0.88
Hospira Inc $66.50 USD +1.11
Patterson Cos Inc $51.20 USD +0.01
View Industry Companies

Industry Analysis


Industry Average

Valuation OCR Industry Range
Price/Earnings 32.2x
Price/Sales 1.2x
Price/Book 2.8x
Price/Cash Flow 110.8x
TEV/Sales 0.8x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OMNICARE INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at